CNS PHARMACEUTICALS INC (CNSP)
US18978H3003 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -17.06M | -18.85M | -15.27M | -14.04M | -9.46M | |||
| Depreciation Amortization | 3.27K | 4.13K | 10.00K | 10.00K | 10.00K | |||
| Change In Working Capital | 1.34M | 3.70M | 3.16M | -1.24M | 830.00K | |||
| Interest Paid | 16.24K | 13.81K | 10.00K | 10.00K | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 1.54M | 1.01M | 1.54M | 1.72M | 1.29M | |||
| OPERATING CASH FLOW | -14.18M | -14.14M | -10.56M | -13.54M | -7.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -3.90K | 0.00 | -10.00K | -20.00K | |||
| INVESTING CASH FLOW | N/A | -3.90K | 0.00 | -10.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -340.29K | -438.73K | -430.00K | -480.00K | -40.00K | |||
| Stock Issued/Repurchased | 20.64M | 5.08M | 16.04M | 4.99M | 14.22M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -50.00K | |||
| FINANCING CASH FLOW | 20.24M | 4.64M | 15.61M | 4.51M | 14.13M | |||
| CHANGE IN CASH | 6.06M | -9.51M | 5.05M | -9.04M | 6.79M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.18M | -14.14M | -10.56M | -13.54M | -7.32M | |||
| Capital Expenditure | N/A | -3.90K | 0.00 | -10.00K | -20.00K | |||
| FREE CASH FLOW | -14.18M | -14.14M | -10.56M | -13.55M | -7.34M | |||
All data in USD